Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Contraindications RYBELSUS and OZEMPIC tablets are contraindicated in patients with: A personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Warnings and Precautions (5.1)]
Hormonal shifts during fast loss can contribute to endocrine changes and hair shedding
( 1 ) Originally approved to treat type 2 diabetes, researchers began creating more targeted versions of GLP-1 medications after it was found that diabetes patients taking the medication often lost weight, sometimes without even intentionally trying
It should be discontinued at least two months before planned conception due to its long half-life
Compounded drugs have not undergone the same FDA review or clinical testing
US$ 21.69
US$ 23.60
US$ 23.64
US$ 28.63
US$ 29.23
US$ 22.00
